Jorge Perea - Publications

Ticagrelor versus clopidogrel in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis.

Journal: Medicina clinica

Published: May 04, 2025

Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement.

Journal: Medicina clinica

Published: March 18, 2025

Mechanical Circulatory Support With Impella in High-Risk Patients With Chronic Total Occlusion and Complex Multivessel Disease.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: October 29, 2024

Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses.

Journal: REC, interventional cardiology

Published: July 22, 2024

The Usefulness of Coregistration with iFR in Tandem or Long Diffuse Coronary Lesions: The iLARDI Randomized Clinical Trial.

Journal: Journal of clinical medicine

Published: June 21, 2024

Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion.

Journal: Frontiers in cardiovascular medicine

Published: June 03, 2024

Percutaneous treatment of the left main coronary artery in older adults. Impact of frailty on mid-term results.

Journal: REC, interventional cardiology

Published: January 14, 2024

Very long-term follow-up after aortic stenting for coarctation of the aorta.

Journal: Revista espanola de cardiologia (English ed.)

Published: August 07, 2023

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?

Journal: Cardiology journal

Published: May 06, 2021

Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study.

Journal: Journal of clinical medicine

Published: December 16, 2020

‌

Ticagrelor versus clopidogrel in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis.

Ticagrelor versus clopidogrel in patients with chronic coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis.

Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement.

Association between subclinical haemolysis and periprocedural outcomes in patients undergoing transcatheter aortic valve replacement.

Mechanical Circulatory Support With Impella in High-Risk Patients With Chronic Total Occlusion and Complex Multivessel Disease.

Mechanical Circulatory Support With Impella in High-Risk Patients With Chronic Total Occlusion and Complex Multivessel Disease.

Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses.

Infectious endocarditis on percutaneous aortic valve prosthesis: comparison with surgical bioprostheses.

The Usefulness of Coregistration with iFR in Tandem or Long Diffuse Coronary Lesions: The iLARDI Randomized Clinical Trial.

The Usefulness of Coregistration with iFR in Tandem or Long Diffuse Coronary Lesions: The iLARDI Randomized Clinical Trial.

Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion.

Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion.

Percutaneous treatment of the left main coronary artery in older adults. Impact of frailty on mid-term results.

Percutaneous treatment of the left main coronary artery in older adults. Impact of frailty on mid-term results.

Very long-term follow-up after aortic stenting for coarctation of the aorta.

Very long-term follow-up after aortic stenting for coarctation of the aorta.

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?

Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study.

Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study.